Clinical Trials Browser

Phase 2 × Squamous NSCLC × Clear all

NCT01861197 2013-05-23

Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer

Phase 2 Unknown

Squamous NSCLC